1-3 of 3
Lucie Oberic
Close
Sort by
Journal Articles

Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial

Vincent Camus, Aurélien Belot, Lucie Oberic, David Sibon, Hervé Ghesquières, Catherine Thieblemont, Christophe Fruchart, Olivier Casasnovas, Jean-Marie Michot, Thierry Jo Molina, André Bosly, Clémentine Joubert, Corinne Haioun, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Olivier Fitoussi, Richard Delarue, Hervé Tilly
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6169–6179.
https://doi.org/10.1182/bloodadvances.2022007609
Published: 2022
Includes: Supplemental data
Journal Articles

Molecular diagnosis of T-cell lymphoma: a correlative study of PCR-based T-cell clonality assessment and targeted NGS

Charlotte Syrykh, Pauline Gorez, Sarah Péricart, David Grand, Frédéric Escudié, Bastien Cabarrou, Lucie Obéric, Loïc Ysebaert, Laurence Lamant, Camille Laurent, Solène M. Evrard, Pierre Brousset
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4590–4593.
https://doi.org/10.1182/bloodadvances.2021005249
Published: 2021
Includes: Supplemental data
Journal Articles

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Laetitia Vercellino, Roberta Di Blasi, Salim Kanoun, Benoit Tessoulin, Cedric Rossi, Maud D'Aveni-Piney, Lucie Obéric, Caroline Bodet-Milin, Pierre Bories, Pierre Olivier, Ingrid Lafon, Alina Berriolo-Riedinger, Eugenio Galli, Sophie Bernard, Marie-Thérèse Rubio, Celine Bossard, Veronique Meignin, Pascal Merlet, Pierre Feugier, Steven Le Gouill, Loic Ysebaert, Olivier Casasnovas, Michel Meignan, Sylvie Chevret, Catherine Thieblemont
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5607–5615.
https://doi.org/10.1182/bloodadvances.2020003001
Published: 2020
Includes: Supplemental data